Netscientific Share Discussion Threads

[4vik] 15/6/2021 19:23

PDSB holding up nicely. Very good sign.

[investordave] 15/6/2021 14:28

35% is a hell of a discount. Surprised it was as big as that.

[nextlink] 15/6/2021 14:27

I think they will increase the percentage of PDS
they hold.

[kalkaar] 15/6/2021 14:23

Be surprised if NSCI don't participate at $8.50

35% discount off yesterday's intra day high..

[kalkaar] 15/6/2021 14:11

5,294,118 shares of its common stock at a public offering price of $8.50 per share. The gross proceeds to PDS Biotech, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $45.0 million. All of the shares of common stock to be sold in the offering are being offered by PDS Biotech. PDS Biotech has granted the underwriters a 30-day option to purchase up to an additional 794,117 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about June 17, 2021.

PDS Biotech intends to use a portion of the net proceeds from this offering for the development of our clinical pipeline and for general corporate purposes including working capital.

[bertiebingo] 15/6/2021 11:51

WH Ireland note very poor, doesn't give numbers so you manually have to calculate NSCI likely exposure

[saint in exile] 15/6/2021 11:20

Well timed Stig

[kalkaar] 15/6/2021 09:01

update from WH Ireland analysts:


NetScientific (NSCI) – Corporate – PDS Biotech – announced public offering after hours

Market Cap £17.7m (£24.8m1 enlarged share capital) Share Price 118p

NetScientific, the international life sciences and sustainability technology investment and commercialisation group, has announced that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has itself announced (after trading hours 14 June) that it is commencing an underwritten public offering of shares of its common stock. PDS intends to use a portion of the net proceeds for the development of its clinical pipeline and the balance for general corporate / working capital purposes. No further details were released with respect to size and pricing.

PDS Biotech’s shares fell 19% in afterhours trading to $10.41 (from $12.86), in response to the announcement, and we would anticipate a further update from PDS in the next 24-48 hours. PDS’s last placing was in August 2020, raising $16.5m at a price of $2.75 through the issue of 6m shares.

WHI View: NetScientific currently retains a 5.75% stake in PDS Biotechnology and has hitherto supported such placings, albeit typically diluted as part of the process. Our last SOTP fair value estimate for NSCI was 162p, with PDS captured at a price of $11.4 (09/06/21) – unrisked value of £10.4m. PDS has demonstrated significant progress in recent months, which has been mirrored in its valuation – with the share price increasing eight fold over the last twelve months. The company is clearly capitalising on this strength as it seeks to develop further its pipeline and to support clinical trials currently in place. NSCI’s CEO, Dr Ilian Iliev, is on PDS’s board.

[blakieboy7] 15/6/2021 07:05

NSCI have RNS'd PDSB update from last night

[the stigologist] 15/6/2021 01:10

NSCI are on Board of PDSB they were clearly inside on PDSB Offering and they want to maintain their stake so obviously raised enough to fund it

This will thus be a mates rates offering before probably some amazing news

Despite rumours of a $9 placing the stock traded at around 10.5 after hours so clearly a lot of strength

[weatherman] 15/6/2021 00:23

Maybe the reason for NSCI placing - may get RNS in morning - graph has changed.

[saint in exile] 14/6/2021 23:26

Dilution is evolution

[investordave] 14/6/2021 22:20

Perhaps that was the reason for the large fall in the share price after hours?

[investordave] 14/6/2021 22:16

I assume the share price will be hit again tomorrow with the dilution in our share of PDSB. Just when I was feeling a tad more optimistic.

[blakieboy7] 14/6/2021 21:32

hTtps://www.otcdynamics.com/pdsb-pds-biotech-announces-proposed-offering-of-common-stock/

[dave4545] 14/6/2021 21:28

I'd certainly take a good slice off.

I was unaware of the after close funding damn I bought back Nsci today, think it would have went mental tomorrow had it not been for that.

[kalkaar] 14/6/2021 21:24

Would you really sell at this point??

If they believed in PDSB 14 months ago when not many did and with all the progress the company has made since I'm not sure they're looking for an exit until PDSB gets taken out or it's valuation hits $1bn+

[dave4545] 14/6/2021 21:18

You'll find it's the whole Nasdaq that is flying.

It's replicating our Dot Com boom of 2000

It's just closed at a all time high and could not rise quick enough at the close with millions of American's piling in blind any tech stock.

If Nsci have any savvy they should be slicing or selling Pdsb while the markets remain
in this bubble.

Actually if they did that today they would have not needed the placing.

[kalkaar] 14/6/2021 21:11

PDSB fund raise - hopefully smart move in advance of good news

[blakieboy7] 14/6/2021 20:48

Get the rockets ready!!

[the stigologist] 14/6/2021 20:40

Hold on to your hats if we get vaccine news on top of Oncology R&D Day this week

[4vik] 14/6/2021 20:40

PDSB breaking out